Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.695 USD | -3.27% | -0.14% | +21.15% |
May. 14 | Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Transcript : Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.15% | 322M | |
+10.75% | 115B | |
+12.16% | 106B | |
-4.36% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-12.92% | 17.56B | |
-40.50% | 17.32B | |
+6.51% | 14.03B | |
+31.06% | 12.13B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals : JPMorgan Starts Atea Pharmaceuticals at Overweight With $45 Price Target